News

DHA Findings Too Weak to Back Use in AD


 

Dr. Yurko-Mauro is the associate director of clinical studies at Martek Biosciences, which sponsored the study; Dr. Quinn reported no potential conflict of interest.

The meeting was sponsored by the Alzheimer's Association.

Pages

Recommended Reading

Hippocampal Atrophy May Predict Alzheimer's
MDedge Psychiatry
Alzheimer Pathology May Belie Dementia Status
MDedge Psychiatry
Statins May Decrease Rate of Dementia by More Than 50%
MDedge Psychiatry
Imaging Suggests Gray Matter Atrophy in MS
MDedge Psychiatry
Ginkgo's Ability to Boost Cognition Comes Up Short–Again
MDedge Psychiatry
Changes in Brain May Herald Dementia in PD : A decrease in the volume of the hippocampus could predict which patients will progress to dementia.
MDedge Psychiatry
Delirium: Apply the ‘4 Ps’ for comprehensive treatment
MDedge Psychiatry
Can a vaccine prevent Alzheimer’s disease?
MDedge Psychiatry
Transdermal rivastigmine for dementia
MDedge Psychiatry
Driving with dementia: How to assess safety behind the wheel
MDedge Psychiatry